BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 18603904)

  • 1. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
    Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Imported visceral leishmaniasis (kala azar) in a German infant].
    Emeis M; Liesenfeld O; Henze G; Meredith S; Schoone G; Stück B
    Klin Padiatr; 1995; 207(6):347-9. PubMed ID: 8569138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
    Guffanti M; Gaiera G; Bossolasco S; Ceserani N; Ratti D; Cinque P; Salmaso F; Gianotti N; Lazzarin A
    Am J Trop Med Hyg; 2008 Nov; 79(5):715-8. PubMed ID: 18981510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute fulminant visceral leishmaniasis in children--a report of two cases.
    Pahwa R; Gupta SK; Singh T; Nigam S
    Indian J Pathol Microbiol; 2004 Jul; 47(3):428-30. PubMed ID: 16295448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hunt for an elusive source of pyrexia in a foreign worker.
    Lew JW; Koh CK; Selvan VS; Shen E
    Singapore Med J; 2007 Apr; 48(4):e111-3. PubMed ID: 17384865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)].
    Just G; Simader R; Helm EB; Stille W; Falk S; Stutte HJ; Hübner K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1920-2. PubMed ID: 2848675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B.
    Erduran E; Bahadir A; Gedik Y
    Pediatr Hematol Oncol; 2005; 22(5):349-55. PubMed ID: 16020124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
    Sayyahfar S; Ansari S; Mohebali M; Behnam B
    Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visceral leishmaniasis].
    Stefaniak J; Paul M; Kacprzak E; Skoryna-Karcz B
    Przegl Epidemiol; 2003; 57(2):341-8. PubMed ID: 12910604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].
    Landmann E; Bogdan C; Donhauser N; Artlich A; Staude B; Gortner L
    Klin Padiatr; 2000; 212(5):266-7. PubMed ID: 11048286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-spleen scintiscan in kala-azar: case report.
    Maniot AL
    J Nucl Med; 1975 Dec; 16(12):1128-9. PubMed ID: 1194960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case report: the efficacy of amphotericin B in visceral leishmaniasis].
    Güleç SG; Kizilyer Y; Karaman S; Erdem E; Urganci N
    Turkiye Parazitol Derg; 2010; 34(2):73-5. PubMed ID: 20597048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis masquerading as chronic liver disease.
    Prakash A; Singh NP; Sridhara G; Malhotra V; Makhija A; Garg D; Pathania A; Agarwal SK
    J Assoc Physicians India; 2006 Nov; 54():893-4. PubMed ID: 17249262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological, clinical and therapeutic features of pediatric kala-azar.
    Rahim KM; Ashkan MM
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.